Reduction of wrinkles and fine lines: Topical application of GHK-Cu at 1-3% significantly improves the depth and volume of wrinkles
Andrew Huberman: And so the animal studies are indeed just animal studies
Others can take 5-30 minutes
The researches of C3 in the pathogenesis of Hashimotos disease shows that the severity and duration of the thyroid dysfunction correlate with the degree of complement activation
The FDA found no clinical studies or publicly available human exposure data for administered MOTS-c, no adequate toxicology, uncertain characterisation and unresolved immunogenicity.[6] The same caution applies to a large range of other non-GLP-1-related peptides that are promoted well beyond the supporting human evidence and in the absence of adequate safety data.[8] Unapproved peptides are not included in the Australian Register of Therapeutic Goods and have not been evaluated by the TGA for safety, quality or effectiveness

Scientific Identifiers Product Name: L-Glutathione (Reduced Form) 1500 mg Catalogue Number: BWP-GSH-1500 CAS Number: 70-18-8 PubChem CID: 124886 Molecular Formula: CHNOS Molecular Weight: 307.33 g/mol Sequence: -Glu-Cys-Gly Type: Linear Tripeptide (L-isomer, Reduced Form) Form: Lyophilised Solid Purity: 99.1 % (HPLC Verified) Storage: Store at 20 C, protected from light Unit Size: 1500 mg Usage and Reconstitution L-Glutathione is supplied as a lyophilised solid to ensure long-term stability